ICYMI: Positive Phase 3 Trial Results for Lennox-Gastaut Syndrome
source: pixabay.com

ICYMI: Positive Phase 3 Trial Results for Lennox-Gastaut Syndrome

Lennox-Gastaut syndrome (LGS) is a form of epilepsy.  Most patients with this condition are resistant to current treatments and experience seizures throughout the duration of their life. They may face…

Continue Reading ICYMI: Positive Phase 3 Trial Results for Lennox-Gastaut Syndrome
Phase 3 Lennox-Gastaut Syndrome Trial Ends in Positive Results
source: pixabay.com

Phase 3 Lennox-Gastaut Syndrome Trial Ends in Positive Results

According to a story from gurufocus.com, the pharmaceutical company Zogenix, Inc., has recently announced top-line results from its phase 3 clinical trial. This trial is testing FINTEPLA® as a treatment…

Continue Reading Phase 3 Lennox-Gastaut Syndrome Trial Ends in Positive Results
CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
source: pixabay.com

CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE

According to a story from BioPortfolio, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its medicine Epidyolex has earned recommendation from the UK National Institute for Health and Care…

Continue Reading CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies
geralt / Pixabay

Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies

According to a story from sectorpublishingintelligence.co.uk, the drug company Ovid Therapeutics Inc. has recently announced that the early data from its phase 2 clinical trial is mostly encouraging. This clinical…

Continue Reading Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies

Enrollment is Complete for Multinational Phase 3 Study for Lennox-Gastaut Syndrome!

Zogenix has just announced that they have not only finished enrollment in their Phase 3 investigation of Fintepla for Lennox-Gastaut Syndrome (LGS), but that the final patient has been randomized…

Continue Reading Enrollment is Complete for Multinational Phase 3 Study for Lennox-Gastaut Syndrome!

A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Cluster Seizures Approximately 1/3 of all epilepsy patients live with uncontrolled seizures. Of these, around 150,000 in the United States alone  experience cluster seizures (otherwise known as acute-repetitive seizures, crescendo…

Continue Reading A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years
Scotland Only Allows 10 Children to Receive New Cannabis-Based Seizure Drug
192635 / Pixabay

Scotland Only Allows 10 Children to Receive New Cannabis-Based Seizure Drug

  There are over 500 children in Scotland whose parents feel could benefit from a new cannabis-derived drug for seizures called Epidiolex. But recently, Secretary Jeanne Freeman had to tell…

Continue Reading Scotland Only Allows 10 Children to Receive New Cannabis-Based Seizure Drug

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Each year the Food and Drug Administration approves dozens of new therapies to fulfill unmet needs for various patient populations. It's just been published that in 2018 they approved a…

Continue Reading A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated

Two Phase 2 clinical trials called ‘Elektra’ and ‘Arcade’ have been initiated. They will investigate the drug OV935/TAK-935 as a potential treatment for paediatric patients with rare epilepsies. For more…

Continue Reading Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated
The Results of a Study of an Investigational Drug for Lennox-Gastaut Syndrome
stevepb / Pixabay

The Results of a Study of an Investigational Drug for Lennox-Gastaut Syndrome

  A study of an investigational drug called ZX008 in patients who have refractory Lennox-Gastaut syndrome has produced promising results, according to Zogenix. For more detailed information, you can view…

Continue Reading The Results of a Study of an Investigational Drug for Lennox-Gastaut Syndrome
Takeda and Ovid Have Provided an Update on the Clinical Development Program for an Investigational Anti-Epileptic Drug
stevepb / Pixabay

Takeda and Ovid Have Provided an Update on the Clinical Development Program for an Investigational Anti-Epileptic Drug

  Takeda Pharmaceutical Company Limited and Ovid Therapeutics have released an overview of the clinical development program for TAK-935/OV935, an investigational drug that is being developed as a potential anti-epileptic…

Continue Reading Takeda and Ovid Have Provided an Update on the Clinical Development Program for an Investigational Anti-Epileptic Drug

ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®

BOHEMIA, N.Y., June 25, 2018 (LGS Foundation) – The LGS Foundation is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol / CBD) for the…

Continue Reading ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®
First Drug Made From Cannabis Approved by the FDA For Dravet Syndrome and Lennox-Gastaut Syndrome
7raysmarketing / Pixabay

First Drug Made From Cannabis Approved by the FDA For Dravet Syndrome and Lennox-Gastaut Syndrome

According to a story from the Washington Post, the US Food and Drug Administration (FDA) has cleared the approval of Epidiolex®, a solution whose active ingredient is a refined version…

Continue Reading First Drug Made From Cannabis Approved by the FDA For Dravet Syndrome and Lennox-Gastaut Syndrome
The UK Government is Being Petitioned to Hold a Referendum on Cannabis
Source: Pixabay

The UK Government is Being Petitioned to Hold a Referendum on Cannabis

The UK government is being petitioned to hold a referendum on the decriminalisation of the drug cannabis. This has implications for people with diseases that may be helped by using…

Continue Reading The UK Government is Being Petitioned to Hold a Referendum on Cannabis
ICYMI: GW Pharmaceuticals Gets FDA Acceptance Letter for New Drug Review
Source: Pixabay

ICYMI: GW Pharmaceuticals Gets FDA Acceptance Letter for New Drug Review

A little more hope is given to individuals suffering from Lennox-Gastaut syndrome and Dravet syndrome as GW Pharmaceuticals shared the U.S. FDA will indeed be accepting their application for potential…

Continue Reading ICYMI: GW Pharmaceuticals Gets FDA Acceptance Letter for New Drug Review
Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru
source: pixabay.com

Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru

The story starts in a Ana Alvarez's flat in Lima, Peru. Soon after, Ana will convert this apartment into a marijuana laboratory and underground medical center. The public will largely sympathize…

Continue Reading Mother’s Underground Marijuana Lab Leads to Legislative Change in Peru
19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 2
Source: Pixabay

19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 2

Check out part 1 of this LGS post here. After prepping: Arrive at the airport early – Ask the airline agent at check-in about getting your wheelchair assistance. Use this…

Continue Reading 19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 2
Close Menu